Patented biomarker for cardiac injury. 

Patented biomarker for cardiac injury. 

Category: Landmark papers

The cMyC 0/1h-algorithm provided excellent safety and identified a greater proportion of patients suitable for direct rule-out or rule-in based on a single measurement than the ESC 0/1h-algorithm using hs-cTnT/I.
Using cMyC to triage on first blood draw results in fewer patients in grey zone compared with hs-cTnT and hs-cTnI.
Discovery of cMyC in the coronary effluent after myocardial infarction.